RPG Life Sciences (NSE:RPGLIFE) Accounts Payable: ₹973 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:RPGLIFE RPG Life Sciences Ltd NSE:RPGLIFE
89 GF Score
Price ₹2,937.00
GF Value ₹2,366.39
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is RPG Life Sciences Accounts Payable?

RPG Life Sciences NSE:RPGLIFE +1.19% 89 Accounts Payable is ₹973 Mil as of Mar. 2026. GuruFocus rates NSE:RPGLIFE with a GF Score™ of 89/100 and a GF Value™ of ₹2,366.39 (Modestly Overvalued). The stock has 5 warning signs investors should review.

RPG Life Sciences's Accounts Payable for the quarter that ended in Mar. 2026 was ₹973 Mil.

RPG Life Sciences's quarterly Accounts Payable declined from Sep. 2025 (₹979 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹973 Mil).

RPG Life Sciences's annual Accounts Payable increased from Mar. 2024 (₹710 Mil) to Mar. 2025 (₹794 Mil) and increased from Mar. 2025 (₹794 Mil) to Mar. 2026 (₹973 Mil).

RPG Life Sciences Accounts Payable Related Terms

RPG Life Sciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for RPG Life Sciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RPG Life Sciences Accounts Payable Chart

RPG Life Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 455.00 646.90 710.20 793.90 972.50

RPG Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 793.90 0.00 979.20 0.00 972.50
NSE:RPGLIFE
89GF Score
RPG Life Sciences Ltd NSE:RPGLIFE
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RPG Life Sciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹973 Mil mean?
RPG Life Sciences (NSE:RPGLIFE) has a Accounts Payable of ₹973 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on RPG Life Sciences and its competitors.
Is RPG Life Sciences' Accounts Payable too high?
RPG Life Sciences' current Accounts Payable is ₹973 Mil. Overall, RPG Life Sciences has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does RPG Life Sciences' Accounts Payable compare to ZTS and UTHR?
RPG Life Sciences' Accounts Payable of ₹973 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on RPG Life Sciences and its competitors. RPG Life Sciences's current Accounts Payable is ₹973 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RPG Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, RPG Life Sciences (NSE:RPGLIFE) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹2,366.39, compared to a current price of ₹2,937.00 — trading 24.1% above its estimated fair value. The current Accounts Payable is ₹973 Mil. RPG Life Sciences' overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For RPG Life Sciences (NSE:RPGLIFE), the current Accounts Payable is ₹973 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, RPG Life Sciences stock appears to be overvalued. The current stock price of ₹2,937.00 is trading 24.1% above its estimated GF Value™ of ₹2,366.39. GuruFocus considers RPG Life Sciences to be Modestly Overvalued.

Key valuation signals for NSE:RPGLIFE:

  • Accounts Payable: ₹973 Mil
  • GF Value™: ₹2,366.39 vs. price of ₹2,937.00 (24.1% above fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RPG Life Sciences Business Description

Other Exchanges 532983:India
Address 463, Dr. Annie Besant Road, RPG House, Near Old Passport Office, Worli, Mumbai, MH, IND, 400030
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
89GF Score

Get the complete analysis for NSE:RPGLIFE

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,937.00
Price
₹2,366.39
GF Value